Skip to main content
. 2020 Nov 25;2020:1392674. doi: 10.1155/2020/1392674

Figure 2.

Figure 2

Impact of LYNX1 expression on overall survival (OS) and disease-specific survival (DSS) in ovarian serous cystadenocarcinoma (OVs) patients in The Cancer Genome Atlas (TCGA) cohort.